Tripti Joshi (Editor)

Pascal Soriot

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Nationality
  
French

Term
  
2012–present

Occupation
  
Businessman

Name
  
Pascal Soriot

Years active
  
1982–present

Role
  
Executive

Title
  
CEO, AstraZeneca


Pascal Soriot Pascal Soriot snaps up 2m in AstraZeneca shares Telegraph

Full Name
  
Pascal Claude Roland Soriot

Born
  
23 May 1959 (age 64) (
1959-05-23
)

Salary
  
GBP £3,507,000 (total compensation)

Alma mater
  
Ecole nationale veterinaire d'Alfort, HEC Paris

Ceo series pascal soriot


Pascal Claude Roland Soriot (born 23 May 1959) is the chief executive (CEO) of the Anglo-Swedish pharmaceutical multinational company AstraZeneca, since October 2012.

Contents

Pascal Soriot Pascal Soriot appointed CEO of AstraZeneca AstraZeneca

In July 2017, it was reported that Soriot would become the next CEO of Israel-based Teva Pharmaceutical Industries, succeeding Erez Vigodman, though this was soon refuted .

Pascal Soriot AstraZeneca chief Pascal Soriot has got his Pfizer

2017 hba woman of the year bahija jallal phd medimmune including intro by pascal soriot


Early life

Pascal Soriot Pascal Soriot AstraZeneca European CEO

He studied veterinary medicine at university (École nationale vétérinaire d'Alfort at Maisons-Alfort in south-east Paris). He later studied at HEC Paris.

Roussel Uclaf

Pascal Soriot City hero and zero 2014 Soriot kept AstraZeneca in UK

In April 1986, he joined Roussel Uclaf (formerly France's second largest pharmaceutical company, until bought by Hoechst AG in 1997) as a salesman, where he lived in Australia. In 1996 he became General Manager of Hoechst Marion Roussel in Australia, moving to Tokyo in April 1997

Aventis

Pascal Soriot mediaphillycomimages20120828pascalsoriot160jpg

In 2000 he moved to Aventis in America, becoming chief operating officer of Aventis USA in 2002, which became Sanofi Aventis USA in 2004.

Roche

He joined Roche in 2006. From April 2009 to 2010 he was chief executive of the Roche subsidiary Genentech. He rejoined Roche Pharma AG in 2010 as chief operating officer.

AstraZeneca

In August 2012 he was named as the new chief executive of AstraZeneca, the world's fifth largest pharmaceutical company, when aged 53. He took up the post on 1 October 2012.

Personal life

He is married with two children.

References

Pascal Soriot Wikipedia